Notable Crowell & Moring
Deals in 2015
2015 Antitrust
M&A Year in Review
AT&T’s $67 Billion
Acquisition of DIRECTV
C&M was lead antitrust counsel for
AT&T in this transaction which created
a more competitive video/broadband
provider. DOJ cleared with no
conditions.
2015 was a record-breaking year for global merger activity,
with the highest recorded volume of announced transactions
at over $5 trillion, approximately half of which involved U.S.
targets.* The year was punctuated by three mega-deals
valued at over $100 billion: Pfizer/Allergan, Dow/DuPont, and
Anheuser-Busch InBev/SABMiller.
Many of the major deals of 2015 are strategic plays, combining competitors to gain
efficiencies, improve innovation and more effectively compete in changing regional and
global markets. That means many of them present challenging competition issues for
regulators in the U.S., Europe, and elsewhere.
By any measure, the agencies rose to the challenge and were extremely active in the
merger enforcement arena. The Department of Justice (DOJ) Antitrust Division challenged
five transactions, four of which were abandoned by the parties and one of which is
pending.
The Federal Trade Commission (FTC) challenged six transactions, four of which are
pending. In addition, between the two U.S. agencies, numerous transactions were cleared
Humana’s Proposed $37 Billion
Merger with Aetna
C&M is representing Humana in
connection with the antitrust review of
its proposed merger with Aetna, which
will combine two highly complementary
health insurance providers in the U.S.
DOJ review pending.
United Technologies’
$9 Billion Sale of Sikorsky
Aircraft to Lockheed Martin
C&M was lead antitrust counsel for UTC
in connection with its divestiture of a
leading helicopter manufacturer to a
premier defense contractor.
DOJ
cleared in initial waiting period.
Europe, Commissioner Vestager made her mark in her first year on a number of high-pro-
Liberty Global’s
Acquisition of De Vijver Media
file merger investigations.
C&M’s Brussels team assisted cable
only after the agencies imposed substantial divestitures and other remedies. And in
operator Liberty Global in this
Several important themes emerge from the agencies’ record on merger enforcement in 2015.
transaction, one of the first EU cases
involving vertical integration between
First, the agencies are increasingly willing to block transactions that they consider
broadcasters and content distribution
harmful to nascent competitors and future innovation in dynamic markets. In April,
platforms.
European Commission (EC)
DOJ, along with the FTC, blocked Comcast’s $45 billion attempt to acquire Time
cleared after a Phase II investigation
Warner Cable, based on concerns that the merger would make Comcast an “unavoid-
and commitments guaranteeing
able gatekeeper” for emerging broadband internet services such as “over the top”
access to De Vijver Media’s channels.
streaming video services like Netflix. Similarly, DOJ worked closely with agencies in
China, Korea and Europe to block the combination of Applied Materials and Tokyo Electron,
Crowell & Moring, LLP | January 2016
*Source: Dealogic
2015 Antitrust M&A Year in Review
. based on concern not about current products but about potential harm to competition for future development of equipment for
next-generation semiconductors.
By contrast, DOJ did not challenge or require remedies in AT&T’s $67 billion acquisition of DIRECTV, concluding that the combination of
the parties’ complementary internet and video businesses “will provide significant benefits to millions of subscribers.” DOJ also did not
challenge Expedia’s acquisition of Orbitz after an extensive investigation, in part because “the online travel business is rapidly evolving.”
A second theme is the agencies will closely
global M&a volume
scrutinize deals even where there is a track record
of prior consolidation in those markets that has
$bn
5,400
18%
not been challenged. In other words, there is a
4,800
16%
tipping point at which the agencies view addition-
4,200
14%
al concentration as likely to harm competition,
3,600
12%
even if prior consolidation has not produced that
3,000
10%
effect. One notable example is the proposed
2,400
8%
acquisition of GE’s home appliance business by
1,800
6%
Electrolux, which followed the Whirlpool/Maytag
1,200
4%
merger in 2006. Notwithstanding their argument
600
2%
that the prior merger proved that consolidation in
0
0%
the industry did not result in higher prices,
2008
2009
Q1
Q2
2010
Q3
2011
2012
Q4
2013
2014
2015
$50bn+ deals as % Share of Total
Source: Dealogic
Electrolux and GE abandoned their transaction in
the middle of the preliminary injunction hearing.
Similar issues may arise in four deals to watch in
2016: Staples/Office Depot (complaint filed by FTC
on Dec.
7); Anheuser-Busch InBev/SABMiller (DOJ review pending); and Aetna/Humana and Anthem/Cigna (DOJ reviews pending).
Third, the agencies have demanded increasingly broader remedies and strong divestiture buyers. For example, the FTC challenged the
Staples/Office Depot merger after months of remedy negotiations with the parties. Similarly, DOJ reportedly has rejected several
remedy proposals in its review of the Baker Hughes/Halliburton transaction.
Notably, the agencies are far more likely to reject product-line carve outs or other narrow divestitures, and demand the sale of entire business entities to maintain the competitive status quo.
Regulators also appear to be increasing their scrutiny of divestiture buyers. Following several unsuccessful merger remedies, including
the Hertz/Dollar Thrifty and Albertson’s/Safeway transactions where divestiture buyers went bankrupt, the agencies are sharpening
their focus to ensure that divestiture buyers will be robust and positioned to quickly replicate lost competition.
Finally, the agencies have demonstrated not only that they are willing to go to court to block deals viewed as harmful to competition,
but have shown they can win those cases. In 2015, the FTC obtained a preliminary injunction blocking the merger of Sysco and US
Foods, and the DOJ was mid-hearing in challenging the Electrolux/GE merger when the parties abandoned the transaction.
The only
defeat in the past year was an adverse decision against the FTC in its effort to block the Steris/Synergy Health transaction based on a
potential competition theory, which failed as a matter of evidentiary proof (not theory).
If the announcements of additional mega-deals in late 2015 foreshadow what is to come, 2016, the last year of the Obama Administration with legacies in the making, may be yet another big year for antitrust merger enforcement. The agencies have proven that they are
taking a very close look, will consider non-traditional theories of harm, are focusing more intensely on the adequacy of proposed
remedies, and will challenge transactions that they view as potentially harmful.
Crowell & Moring, LLP | January 2016
. telecom
In 2015, the DOJ and Federal Communication Commission (FCC) reviewed two of the largest telecom
deals in U.S. history: Comcast’s $45.2 billion proposed acquisition of Time Warner Cable, and AT&T’s
$67 billion acquisition of DIRECTV. The regulatory paths of these deals went in starkly opposite directions.
The proposed Comcast/TWC transaction
involved the combination of the two largest
U.S. cable operators, but significantly they do
not compete for customers in any overlapping
U.S.
M&A Activity –
telecom sector
$465
geographic area. Regulators nevertheless were
concerned about the fact that the combination
$310
would have created a company with the most
$260
broadband and video subscribers in the nation
alongside the ownership of significant pro-
$300
$210
graming interests. As such, the agencies feared
that Comcast/TWC would be able to harm
emerging competition from new “over the
top” video services, like Netflix, that are
dependent on broadband distribution.
DOJ
concluded that the transaction would have
made Comcast “an unavoidable gatekeeper”
Median Transaction Value (millions)
Data reflects statistics for transactions greater than $50M.
Source: S&P Capital IQ / McGraw Hill Financial.
for such internet based services.
In contrast, the DOJ and FCC agreed that AT&T’s proposed acquisition of DIRECTV would create “a more effective MVPD competitor, offering consumers greater choices at lower prices.” Although there was some overlap in the areas in which both companies
provided video service, the parties explained why neither had the assets necessary to effectively compete against the larger
providers of broadband/video bundles. DIRECTV, as a direct-broadcast satellite provider, lacked broadband capabilities. And
AT&T’s video product was limited, and cost-disadvantaged, by its relatively small footprint and subscriber base.
The integration of cable and content providers was front and center in the EC’s review of Belgian cable operator Telenet’s proposed acquisition of TV broadcaster and production company De Vijver Media (DVM).
This was one of the first times the EC
analyzed the vertical integration of a cable operator with a distribution platform and a content provider. After a Phase II investigation to assess the risk of foreclosure at both the content and distribution levels, the Commission eventually approved the transaction subject to limited commitments regarding the licensing of DVM’s channels to third parties on non-discriminatory terms.
In 2015, the Department of Justice and Federal Communications Commission
reviewed two of the largest telecom deals in U.S. history ....
The regulatory paths
of these deals went in starkly opposite directions.
2015 Antitrust M&A Year in Review
. health care
2015 marks five years since the passage of the Patient Protection and
Affordable Care Act (ACA). With its goal of controlling health care costs
while improving quality, ACA is prompting a shift toward value-and riskbased payment models, technology-based health care, and increased
focus on primary and coordinated care.
U.S. M&A Activity
– Health Care
Sector
2011
These changes have spurred consolidation by both payors and providers, and corresponding
scrutiny by the antitrust agencies. The head enforcers at both DOJ and FTC have reiterated
that the goals of health care reform do not supplant competition policy, and the agencies will
$24.5
million
scrutinize transactions that threaten to harm competition.
The review process will examine
payor and provider claims that consolidation will lead to higher quality health care at more
affordable prices for more consumers, as the agencies question whether transactions will
2012
raise prices or adversely affect quality.
•
Provider consolidation: In early 2015, the Ninth Circuit upheld the FTC’s and State of
$23.25
million
Idaho’s challenge to St. Luke’s Health System’s consummated 2012 acquisition of
Saltzer Medical Group, rejecting the parties’ efficiencies arguments as not merger
specific. As hospital and physician group transactions continued throughout the year,
2013
the FTC has remained vigilant, with recent challenges to hospital mergers in Pennsylvania, West Virginia, and Illinois, and settlements requiring remedies in other transactions.
•
Payor combinations: The biggest headlines in 2015 were Aetna’s proposed acquisition
of Humana and Anthem’s proposed acquisition of Cigna.
The transactions, which are
pending review by DOJ, have attracted attention due to their size, but the parties have
emphasized that the mergers bring together companies with significant complementarity and potential to improve health care.
•
$19
million
2014
$20.5
million
Health care services consolidation: Companies providing critical services to the health
care industry have consolidated as they have faced increasing marketplace challenges.
The FTC has required remedies to clear several mergers in medical device industries
2015 YTD thru 12/22
involving overlapping products. By contrast, Cerner successfully acquired Siemens Health
Services, based on the parties’ evidence that the transaction would accelerate the
introduction of next-generation health IT solutions.
The head enforcers at both the DOJ and FTC have reiterated
that the goals of health care reform do not supplant
competition policy, and agencies will scrutinize transactions
that threaten to harm competition.
Crowell & Moring, LLP | January 2016
$30
million
Median Transaction Value
Data reflects statistics for all
announced U.S. healthcare
transactions with disclosed
value.
Source: S&P Capital IQ /
McGraw Hill Financial
. energy
Against a prolonged era of low commodity prices, energy companies are seeing
[D]eal activity in the
midstream segment
dominates the statistics
.... Analysts predict that
2016 may prove to be
a need for strategic alternatives to survive and thrive in a challenging market
environment. Some deals in the producer segments, including upstream coal,
natural gas, and oil companies, have moved forward but heavy exposure to
commodity pricing has created headwinds for upstream deals in the capital
markets. By contrast, deal activity in the midstream segment dominates the
statistics.
According to PwC, during the third quarter of 2015, 14 midstream
deals accounted for over 70% of deal value in the oil and gas sector. Analysts
an even stronger year
predict that 2016 may prove to be an even stronger year for midstream
for midstream
megadeals.
megadeals.
Midstream deals are driven not only by the need for scale and synergies, but
the desire for growth in returns to investors as U.S. production levels have
declined.
Some of the most high profile deals involve master limited partnerships that distribute most income to investors. More than 100 MLPs exist in the
energy infrastructure space, and serve as key growth vehicles for companies able to acquire strategic assets. Antitrust review
of acquisitions of and by MLPs has become increasingly complex, as more transactions involve fractional ownership arrangements in which operating control is divorced from ownership interests and governance.
Companies that aggressively pursue
MLP strategies will benefit from stepped up due diligence on such issues to minimize the risk of investigations or delayed deal
execution associated with merger reviews.
intellectual property and innovation
The most recent Horizontal Merger Guidelines put innovation squarely at issue
in merger analysis, and firms that compete in sectors where innovation and
intellectual property drive the competitive dynamics must be prepared to
respond to novel theories of harm to get the deal done. In 2015 Applied
The most recent
Horizontal Merger
Materials and Tokyo Electron abandoned plans to merge their semiconductor
Guidelines put
manufacturing equipment businesses, which would have combined the two
innovation squarely
largest competitors with the necessary know-how, resources, and ability to
develop such equipment.
at issue in merger
analysis ....
Although the parties offered to divest overlapping products, DOJ rejected the
proposed remedy because it would not restore competition with respect to
R&D scale and resources required to continue the rapid advance of innovation
in the industry. According to DOJ, “the proposed remedy would not have replaced the competition eliminated by the
merger, particularly with respect to the development of equipment for next-generation semiconductors.”
2015 Antitrust M&A Year in Review
.
expanding involvement of third parties
Third parties – including competitors, customers, and participants in
[T]he agencies now welcome third
party involvement as a means to
gain insight into market dynamics
.... and to improve their analysis.
adjacent markets – have become increasingly active in the merger
review process. Once viewed with great skepticism that third parties
are driven by incentives to disrupt efficient consolidation or gain
leverage for commercial reasons, the agencies now welcome third
party involvement as a means to gain insight into market dynamics,
learn the nuances of competition in complex, dynamic industries,
and get access to documents and information to improve their
analysis. However, third parties have to consider whether their goal
is to block the deal, influence the remedies imposed, or shape the agency’s view of market dynamics for the analysis of future
deals, as well as whether their advocacy could have collateral legal or commercial risks.
Examples of 2015 deals in which third parties played pivotal roles:
•
Sysco/US Foods (FTC): Large national food service management companies helped convince the court that they were
uniquely dependent on the two top (merging) distributors, and would be competitively harmed by the merger notwithstanding the multitude of smaller distributors the parties claimed to compete with.
•
Expedia/Orbitz (DOJ): Extensive evidence from the travel industry helped DOJ conclude that, notwithstanding the
presence of smaller online travel agencies, multiple metasearch companies, and recent entry by Google and Trip Advisor,
the merger would reduce from 3 to 2 the number of online search and booking companies.
While DOJ cleared the
transaction based on evidence suggesting the merger would not result in a price increase, the intervenors were able to
shape DOJ’s understanding of the unique market presence of large, global OTAs.
antitrust merger
investigations: e-discovery,
timing and cost
In August 2015, the FTC issued
a revised model Second
Request, which imposes new
Merger investigations are becoming longer and more costly, which may
obligations on merging parties
be in part a result of the cost and burden of collecting, reviewing and
with respect to the use of
producing large volumes of electronic information. The ABA recently
conducted a “Second Request Cost Survey,” which reported that the
predictive coding or
median length of a merger investigation involving a Second Request
technology-assisted review,
among those surveyed was approximately 7 to 8 months, with a range
from 2.25 to 12 months. The survey also found that the average cost of
compliance with a Second Request was $4.3 million, with a range of
$2-9 million.
Practitioners observe that both cost and timelines in U.S.
merger investigations have steadily increased over the past decade.
Crowell & Moring, LLP | January 2016
identification and production
of databases, and creation of
‘data maps.’
. One cause of this trend is the vast amount of electronic documents and data requested by the DOJ and FTC in Second Requests, and
the challenges companies have in quickly negotiating and complying with those requests. In August 2015, the FTC issued a revised
model Second Request, which imposes new obligations on merging parties with respect to the use of predictive coding or technology
assisted review, identification and production of databases, and creation of “data maps.” The DOJ has long imposed similar requirements with respect to predictive coding and databases. These requirements, though process-oriented, give the agencies additional
leverage in the overall merger review by making compliance virtually impossible on any timetable other than that to which the
government agrees.
europe: commissioner vestager’s first year
Since taking her post in November 2014,
Commissioner Margrethe Vestager has
established herself as an economically
2015 saw the highest number of Phase II merger
sophisticated head of the European
investigations (11) initiated by the Commission since
Commission’s Competition Directorate
2007 and the highest number of Phase II clearances
whose decision-making is tempered with
subject to commitments (7) since 2001.
both pragmatism and the protection of
consumer welfare.
2015 saw the highest number of Phase II merger investigations (11) initiated by the Commission since 2007 and the highest
number of Phase II clearances subject to commitments (7) since 2001. This may reflect a higher level of M&A activity generally,
or signal that the new Commissioner has a more cautious attitude toward mergers.
In particular, Commissioner Vestager has expressed skepticism as to the efficiencies generated by telecoms mergers, particularly
four-to-three mobile mergers in national telecom markets, several of which were cleared by her predecessor, Joachim Almunia.
At the same time, Vestager seems to have retained much of Almunia’s ability to find creative solutions and clear difficult cases.
GE/Alstom – a merger of two of the three main producers of heavy duty gas turbines in Europe, with combined market shares in
excess of 50% – was seen as Vestager’s first major test in a difficult merger, and resulted in clearance subject to a major divestment to a fringe player.
The Commissioner’s statement following the case was perhaps telling: “I am glad that we can approve
this transaction, which shows that Europe is open for business.”
Copyright © 2016 by Crowell & Moring LLP. All rights reserved. This material is for general information purposes only and does not represent our legal advice as to
any particular set of facts, nor does it represent any undertaking to keep recipients advised of all relevant legal developments.
2015 Antitrust M&A Year in Review
.
overview of our Antitrust M&A practice
Crowell & Moring has successfully handled the antitrust clearance of some of the largest and most complex mergers and
acquisitions in recent history. We pride ourselves on guiding our clients through the review of their most important strategic
transactions. Our track record of favorable outcomes speaks for itself.
We have one of the largest and most active antitrust mergers and acquisitions practices around. It is not uncommon for our
firm to handle several second requests and Phase II investigations each year, while working closely with the antitrust agencies
in many cases to resolve matters in the initial waiting period.
Our M&A practice takes clients from antitrust planning in the initial stages of a transaction through the premerger notification
process (often in multiple jurisdictions globally), responding to second requests from the Federal Trade Commission or Department of Justice, or investigative demands by other national or state agencies, negotiating or litigating final resolution of
antitrust issues, and representing clients in court proceedings to secure final approval of merger remedies.
We also counsel
clients in a broad range of joint ventures, collaborations, and marketing and distribution alliances.
Our strategy is to form long-standing client relationships and to invest in developing deep understanding of our clients’
businesses. We use that knowledge to identify transactions that are likely to attract significant scrutiny and to prepare our
clients to manage the merger review process, rather than be managed by it. Where appropriate, we begin the advocacy
process in advance, positioning the company to respond quickly to any demands for documents and information and to avoid
delays to the transaction’s consummation.
We have deep experience working with the antitrust and competition agencies
and, when necessary, are prepared to litigate a government challenge.
contact us
Wm. Randolph Smith
Thomas De Meese
Mary Anne Mason
Michael G. Van Arsdall
Antitrust Group Chair, Partner
Partner
Partner
Senior Counsel
wrsmith@crowell.com
tdemeese@crowell.com
mamason@crowell.com
mvanarsdall@crowell.com
202.624.2700
+32.2.282.1842
202.624.2572
202.624.2782
Olivier N.
Antoine
Shawn R. Johnson
Joseph M. Miller
Partner
Partner
Partner
oantoine@crowell.com
srjohnson@crowell.com
joemiller@crowell.com
212.803.4022
202.624.2624
202.624.2809
Sean-Paul Brankin
Lisa Kimmel
Jeane A.
Thomas
Partner
Senior Counsel
Partner
sbrankin@crowell.com
lkimmel@crowell.com
jthomas@crowell.com
+32.2.282.1830
202.624.2749
202.624.2877
Dr. Salomé Cisnal de Ugarte
Arthur N. Lerner
Ryan C.
Tisch
Partner
Partner
Partner
scisnaldeugarte@crowell.com
alerner@crowell.com
rtisch@crowell.com
+32.2.214.2837
202.624.2820
202.624.2674
Crowell & Moring, LLP | January 2016
For more information
about our Antitrust M&A
practice, visit our website
crowell.com.
.